Loading...

Sarah Goglin, MD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Address400 Parnassus Avenue
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCSFFellowship2015Rheumatology
    UCSFResidency2012Internal Medicine
    Columbia UniversityMD2009School of Medicine
    Stanford UniversityBA2004Human Biology
    Collapse Awards and Honors
    UCSF2016Ira M. Goldstein Award for Outstanding Teaching in Rheumatology
    UCSF2015Calvin L. Chou PRIME Teaching Award
    2014American College of Rheumatology Distinguished Fellow Award
    Columbia University2009AOA

    Collapse Overview 
    Collapse Overview
    Sarah Goglin is a physician who specializes in rheumatology, with a clinical focus on lupus and the systemic vasculitides. She joined UCSF in 2009 and currently practices at the UCSF Rheumatology Faculty Practice, as well as in the Zuckerburg San Francisco General Rheumatology clinic. She also attends on the inpatient rheumatology consultation service at the Moffitt-Long Hospital. Presently, she is an Assistant Clinical Professor in the Division of Rheumatology and Department of Medicine.

    Sarah's academic interests include medical education. She is a coach in the UCSF School of Medicine, where she serves as faculty in the Clinical Microsystems Clerkship. She also serves as an instructor and small group leader for the Infection, Immunity, and Inflammation block in the School of Medicine. Sarah also leads the UCSF Medicine Residency Intern and Resident Half Days.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Goglin SE, Farzaneh-Far R, Epel ES, Lin J, Blackburn EH, Whooley MA. Correction: Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study. PLoS One. 2016; 11(12):e0168868. PMID: 27992608.
      View in: PubMed
    2. Goglin SE, Farzaneh-Far R, Epel ES, Lin J, Blackburn EH, Whooley MA. Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study. PLoS One. 2016; 11(10):e0160748. PMID: 27783614.
      View in: PubMed
    Co-Authors
    People in Profiles who have published with this person.
    _
    Back to TOP